InMed Pharmaceuticals INM
NASDAQ INM
$1.36 -0.02 (-1.45%)
At close: Sep 30, 2026 · 4:00 PM EDT

InMed Pharmaceuticals (INM) Current Deferred Revenue (2021 - 2023)

Updated

InMed Pharmaceuticals (INM) reported Current Deferred Revenue of $16,171 for fiscal Q3 2023 (quarter ended Mar 31, 2023), up 81.7% from $8,902 a year earlier and unchanged from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Current Deferred Revenue (2021 - 2023) Analysis & Trends

Dating back to fiscal Q2 2022, InMed Pharmaceuticals' Current Deferred Revenue record includes 5 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 218.80 Bn 201.92 Bn 4.43 Bn
2 Corning 132.43 Bn 125.56 Bn 1.63 Bn
3 Sherwin Williams 78.49 Bn 77.53 Bn 3.34 Bn
4 Air Products & Chemicals 61.97 Bn 59.87 Bn 1.04 Bn
5 Corteva 51.82 Bn 40.62 Bn 3.66 Bn
6 LyondellBasell Industries 37.12 Bn 26.74 Bn 2.04 Bn
7 Nutrien 33.86 Bn 30.73 Bn 3.25 Bn
8 Qnity Electronics 26.31 Bn 23.73 Bn 666.00 Mn
9 Ati 25.78 Bn 23.93 Bn 309.80 Mn
10 InMed Pharmaceuticals 5.66 Mn 3.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 16,171.00
Dec 31, 2022 16,171.00
Sep 30, 2022 15,700.00
Mar 31, 2022 8,902.00
Dec 31, 2021 8,390.00
API Access

InMed Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=INM&period=max&api_key=YOUR_API_KEY